β-Catenin-Driven Cancers Require a YAP1 Transcriptional Complex for Survival and Tumorigenesis
Rosenbluh, Joseph, Nijhawan, Deepak, Cox, Andrew G., Li, Xingnan, Neal, James T., Schafer, Eric J., Zack, Travis I., Wang, Xiaoxing +13 more·2012·Cell
Cited by (759)
Items 201–300 of 759
- WNK Kinases in Development and DiseaseAylin R. Rodan, Andreas Jenny · 2016 · Current topics in developmental biology/Current Topics in Developmental Biology
- Platelet‐derived growth factor regulates YAP transcriptional activity via Src family kinase dependent tyrosine phosphorylationRory L. Smoot, Nathan W. Werneburg, Takaaki Sugihara, Matthew C. Hernandez, Lin Yang, Christine Mehner, Rondell Patrell Graham, Steven F. Bronk, Mark Joseph Truty, Gregory James Gores · 2017 · Journal of Cellular Biochemistry
- Dual inhibition of Wnt and Yes‐associated protein signaling retards the growth of triple‐negative breast cancer in both mesenchymal and epithelial statesAndrew Sulaiman, Sarah McGarry, Li Li, Deyong Jia, Sarah Ooi, Christina Addison, Jim Dimitroulakos, Angel Arnaout, Carolyn Nessim, Zemin Yao et al. · 2018 · Molecular Oncology
- The Roles of Hippo Signaling Transducers Yap and Taz in Chromatin RemodelingRyan E. Hillmer, Brian A. Link · 2019 · Cells
- Genome-scale CRISPR-Cas9 screen of Wnt/β-catenin signaling identifies therapeutic targets for colorectal cancerChunhua Wan, Sylvia Mahara, Claire Xin Sun, Anh Doan, Hui Kheng Chua, Dakang Xu, Jia Bian, Yue Li, Danxi Zhu, Dhanya Sooraj et al. · 2021 · Science Advances
- Nerves in gastrointestinal cancer: from mechanism to modulationsNathalie Vaes, Musa Idris, Werend Boesmans, Maria M. Alves, Veerle Melotte · 2022 · Nature Reviews Gastroenterology & Hepatology
- Genetic and Proteomic Interrogation of Lower Confidence Candidate Genes Reveals Signaling Networks in β-Catenin-Active CancersJoseph Rosenbluh, Johnathan Mercer, Yashaswi Shrestha, Rachel Oliver, Pablo Tamayo, John G. Doench, Itay Tirosh, Federica Piccioni, Ella Hartenian, Heiko Horn et al. · 2016 · Cell Systems
- Mechanosensation to inflammation: Roles for YAP/TAZ in innate immune cellsVijaykumar S. Meli, Praveen Krishna Veerasubramanian, Timothy L. Downing, Wenqi Wang, Wendy F. Liu · 2023 · Science Signaling
- Hippo pathway and breast cancer stem cellsMarcello Maugeri‐Saccà, Ruggero D. Maria · 2015 · Critical Reviews in Oncology/Hematology
- IL‐6/YAP1/β‐catenin signaling is involved in intervertebral disc degenerationJian Chen, Zheng-Feng Mei, Bao Hua Huang, Xuyang Zhang, Junhui Liu, Zhi Shan, Jiasheng Wang, Xianjun Wang, Fengdong Zhao · 2018 · Journal of Cellular Physiology
- The Hippo pathway in disease and therapy: cancer and beyondMarta Gómez-Ferrer, Valentí Gómez, Alexander Hergovich · 2014 · Clinical and Translational Medicine
- Cis-regulatory architecture of a brain signaling center predates the origin of chordatesYao Yao, Paul J Minor, Ying-Tao Zhao, Yongsu Jeong, Ariel M. Pani, Anna N. King, Orsolya Symmons, Lin Gan, Wellington Veras Cardoso, François Spitz et al. · 2016 · Nature Genetics
- Genome-wide association study identifies three susceptibility loci for laryngeal squamous cell carcinoma in the Chinese populationQingyi Wei, Dianke Yu, Mingbo Liu, Mengyun Wang, Miaoqing Zhao, Ming Liu, Wei‐Hua Jia, Hongxia Ma, Jugao Fang, Wei Xu et al. · 2014 · Nature Genetics
- T-box transcription factors in cancer biologySabina Maria Wansleben, Jade Peres, Shannagh Hare, Colin R. Goding, Sharon Prince · 2014 · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer
- Intracellular Signals Activated by Canonical Wnt Ligands Independent of GSK3 Inhibition and β-Catenin StabilizationAntonio Garcı́a de Herreros, Mireia Duñach · 2019 · Cells
- Collagen Kinase Receptors as Potential Therapeutic Targets in Metastatic Colon CancerMarie Lafitte, Audrey Sirvent, Serge Roche · 2020 · Frontiers in Oncology
- ABHD5 inhibits YAP-induced c-Met overexpression and colon cancer cell stemness via suppressing YAP methylationYan Jennifer Gu, Yanrong Chen, Lai Wei, Shuang Wu, Kaicheng Shen, Chengxiang Liu, Yan Dong, Zhao Yang, Yue Zhang, Chi Zhang et al. · 2021 · Nature Communications
- The Hippo–YAP/TAZ Signaling Pathway in Intestinal Self-Renewal and Regeneration After InjuryFeihong Deng, Zengrong Wu, Fei Zou, Su Wang, Xuehong Wang · 2022 · Frontiers in Cell and Developmental Biology
- TTK Inhibitors as a Targeted Therapy for CTNNB1 ( β -catenin) Mutant CancersGuido J.R. Zaman, Jeroen A.D.M. de Roos, Marion A.A. Libouban, Martine B.W. Prinsen, Jos de Man, Rogier C. Buijsman, Joost C.M. Uitdehaag · 2017 · Molecular Cancer Therapeutics
- New insights into the Hippo/YAP pathway in idiopathic pulmonary fibrosisMingyao Sun, Yangyang Sun, Ziru Feng, Xinliang Kang, Weijie Yang, Yongan Wang, Yuan Luo · 2021 · Pharmacological Research
- Crosstalk between Hypoxia and Extracellular Matrix in the Tumor Microenvironment in Breast CancerYasmin Dekker, Sylvia E. Le Dévédec, Erik H.J. Danen, Qiuyu Liu · 2022 · Genes
- Inhibition of YAP/TAZ-driven TEAD activity prevents growth of NF2-null schwannoma and meningiomaLiyam Laraba, Lily Hillson, Julio Grimm de Guibert, Amy Hewitt, Maisie R. Jaques, Tracy Tzu-Ling Tang, Leonard E. Post, Emanuela Ercolano, Ganesha Rai, Shyh‐Ming Yang et al. · 2022 · Brain
- A combinatorial strategy using YAP and pan-RAF inhibitors for treating KRAS-mutant pancreatic cancerXiao Zhao, Xiuchao Wang, Lijun Fang, Chungen Lan, Xiaowei Zheng, Yongwei Wang, Yinlong Zhang, Xuexiang Han, Shaoli Liu, Keman Cheng et al. · 2017 · Cancer Letters
- LncRNA‐CCAT5‐mediated crosstalk between Wnt/β‐Catenin and STAT3 signaling suggests novel therapeutic approaches for metastatic gastric cancer with high Wnt activityChenchen Liu, Aiwen Shen, Junquan Song, Lei Cheng, Meng Zhang, Yanong Wang, Xiaowen Liu · 2023 · 癌症:英文版
- Yap control of tissue growth relies on cell density and F-actin in zebrafish fin regenerationRita Mateus, Raquel Lourenço, Yi Fang, Gonçalo Brito, Ana Farinho, Fábio Valério, António Jacinto · 2015 · Development
- Inactivation of hypoxia-induced YAP by statins overcomes hypoxic resistance tosorafenib in hepatocellular carcinoma cellsTianyi Zhou, Linhan Zhuang, Yan Wei Hu, Yulu Zhou, Wenkai Lin, Dandan Wang, Zi-qian Wan, Lin-lin Chang, Ying Chen, Meidan Ying et al. · 2016 · Scientific Reports
- An integrated genomic analysis of anaplastic meningioma identifies prognostic molecular signaturesGrace Collord, Patrick S. Tarpey, Natalja Kurbatova, Iñigo Martincorena, Sebastián Morán, Manuel Castro de Moura, Tibor Nagy, Graham R. Bignell, Francesco Maura, Matthew D. Young et al. · 2018 · Scientific Reports
- Hypoxia-inducible factor 2α (HIF-2α) promotes colon cancer growth by potentiating Yes-associated protein 1 (YAP1) activityXiaoya Ma, Huabing Zhang, Xiang Xue, Yatrik Madhukar Shah · 2017 · Journal of Biological Chemistry
- Regulation of Myocardial Cell Growth and Death by the Hippo PathwayShohei Ikeda, Junichi Sadoshima · 2016 · Circulation Journal
- PLAGL2 promotes epithelial–mesenchymal transition and mediates colorectal cancer metastasis via β-catenin-dependent regulation of ZEB1Liang Wu, Zili Zhou, Shengbo Han, Jinhuang Chen, Zhengyi Liu, Xudan Zhang, Wenzheng Yuan, Jintong Ji, Xiaogang Shu · 2019 · British Journal of Cancer
- Endogenous Retrovirus-Derived lncRNA BANCR Promotes Cardiomyocyte Migration in Humans and Non-human PrimatesKitchener D. Wilson, Mohamed Ameen, Hong-Chao Guo, Oscar J. Abilez, Lei Tian, Maxwell R. Mumbach, Sebastian Diecke, Xulei Qin, Yonggang Liu, Hua-Xiao Yang et al. · 2020 · Developmental Cell
- Emerging Principles in the Transcriptional Control by YAP and TAZAlejandro Lopez-Hernandez, Silvia Sberna, Stefano Campaner · 2021 · Cancers
- FGF8 promotes colorectal cancer growth and metastasis by activating YAP1Rui R Liu, Shan Huang, Yunlong Lei, Tao Zhang, Kui Wang, Bo Liu, Edouard Collins Nice, Rong Xiang, Ke Xie, Jingyi Li et al. · 2014 · Oncotarget
- Rho-mediated signaling promotes BRAF inhibitor resistance in de-differentiated melanoma cellsSean A. Misek, Kate M. Appleton, Thomas Steven Dexheimer, Erika Mathes Lisabeth, Roger S. Lo, Scott D. Larsen, Kathleen A. Gallo, Richard R. Neubig · 2019 · Oncogene
- c-Abl antagonizes the YAP oncogenic functionRom Keshet, Julia Adler, Inna Ricardo-Lax, Matan Shanzer, Ziv Porat, Nina Bacher Reuven, Yosef Shaul · 2014 · Cell Death and Differentiation
- MicroRNA profiling of cisplatin-resistant oral squamous cell carcinoma cell lines enriched with cancer-stem-cell-like and epithelial-mesenchymal transition-type featuresRuma Dey Ghosh, Sangeeta Ghuwalewala, Pijush K. Das, Sapan Mandloi, Sk. Kayum Alam, Jayanta Chakraborty, Sajal Sarkar, Saikat Chakrabarti, Chinmoy Kumar Panda, Susanta Roychoudhury · 2016 · Scientific Reports
- The NDR/LATS protein kinases in immunology and cancer biologyAhmad A.D. Sharif, Alexander Hergovich · 2017 · Seminars in Cancer Biology
- YAP1-TEAD1 signaling controls angiogenesis and mitochondrial biogenesis through PGC1αAkiko Mammoto, Megan Muyleart, Andrew O. Kadlec, David D. Gutterman, Tadanori Mammoto · 2018 · Microvascular Research
- Correlations between TBL1XR1 and recurrence of colorectal cancerHongda Liu, Yunfei Xu, Qun Zhang, Kangshuai Li, Dawei Wang, Shuo Li, Shanglei Ning, Hui Yang, Weichen Shi, Zhaochen Liu et al. · 2017 · Scientific Reports
- MicroRNA deregulation in nonalcoholic steatohepatitis-associated liver carcinogenesisAline de Conti, Juliana Festa Ortega, Volodymyr Tryndyak, Kostiantyn Dreval, Fernando Salvador Moreno, Ivan Rusyn, Frederick A. Beland, Igor P. Pogribny · 2017 · Oncotarget
- YAP/TAZ-Mediated Upregulation of GAB2 Leads to Increased Sensitivity to Growth Factor–Induced Activation of the PI3K PathwayChao Wang, Chao Gu, Kang Jin Jeong, Dong Zhang, Wei Guo, Yiling Lu, Zhenlin Ju, Nattapon Panupinthu, Ji Yeon Yang, Mihai Gagea et al. · 2017 · Cancer Research
- Transcriptional co-activators YAP/TAZ: Potential therapeutic targets for metastatic breast cancerWenxia Zhao, Mengyan Wang, Meilian Cai, Cong-Hui Zhang, Yuhan Qiu, Xiaowei Wang, Tianshu Zhang, Huimin Zhou, Junxia Wang, Wuli Zhao et al. · 2020 · Biomedicine & Pharmacotherapy
- Synthetic Essentiality of Tryptophan 2,3-Dioxygenase 2 in APC -Mutated Colorectal CancerRumi Lee, Jiexi Li, Jun Li, Chang‐Jiun Wu, Shan Jiang, Wen-Hao Hsu, Deepavali Chakravarti, Peiwen Chen, Kyle A. LaBella, Jing Li et al. · 2022 · Cancer Discovery
- New Insights into YAP/TAZ-TEAD-Mediated Gene Regulation and Biological Processes in CancerYang Zhao, Marisela Sheldon, Yutong Sun, Li Ma · 2023 · Cancers
- Wnt/β-catenin signaling regulates follicular development by modulating the expression of Foxo3a signaling componentsLei Li, Shaoyang Ji, Junling Yang, Xixia Li, Jun Zhang, Yang Zhang, Zhao‐Yuan Hu, Yixun Liu · 2013 · Molecular and Cellular Endocrinology
- Aurora A kinase activates YAP signaling in triple-negative breast cancerS.H. Chang, Hirohito Yamaguchi, W Xia, S-O Lim, Yekaterina B. Khotskaya, Yun Wu, W-C Chang, Qinqin Liu, Mien‐Chie Hung · 2016 · Oncogene
- Factors Affecting the Nuclear Localization of β‐Catenin in Normal and Malignant TissueRhys G. Morgan, Jenna Ridsdale, Alex Tonks, Richard L. Darley · 2014 · Journal of Cellular Biochemistry
- The dual functions of YAP-1 to promote and inhibit cell growth in human malignancyHai Wang, Yu Chen Du, Xiao Jun Zhou, Hong Liu, Shou‐Ching Tang · 2013 · Cancer and Metastasis Reviews
- Hippo signalling in intestinal regeneration and cancerAlex Gregorieff, Jeffrey L. Wrana · 2017 · Current Opinion in Cell Biology
- Hippo‐yap signaling in ocular development and diseaseMatthew Lee, Navneet Goraya, Seonhee Kim, Seo‐Hee Cho · 2018 · Developmental Dynamics
- Towards a compendium of essential genes – From model organisms to synthetic lethality in cancer cellsTianzuo Zhan, Michael Boutros · 2015 · Critical Reviews in Biochemistry and Molecular Biology
- YES1 Is a Targetable Oncogene in Cancers Harboring YES1 Gene AmplificationNatsuki Hamanaka, Yoshito Nakanishi, Takakazu Mizuno, Kana Horiguchi-Takei, Nukinori Akiyama, Hiromi Tanimura, Masami Hasegawa, Yasuko Satoh, Yukako Tachibana, Toshihiko Fujii et al. · 2019 · Cancer Research
- YAP‑mediated crosstalk between the Wnt and Hippo signaling pathways (ReviewLiya Jiang, Juan Li, Chenxing Zhang, Yufeng Shang, Jun Lin · 2020 · Molecular Medicine Reports
- YES1: A Novel Therapeutic Target and Biomarker in CancerIrati Garmendia, Esther Redín, Luis M. Montuenga, Alfonso Calvo · 2022 · Molecular Cancer Therapeutics
- Targeting a Lipid Desaturation Enzyme, SCD1, Selectively Eliminates Colon Cancer Stem Cells through the Suppression of Wnt and NOTCH SignalingYeongji Yu, Hyejin Kim, SeokGyeong Choi, Jinsuh Yu, Joo Yeon Lee, Hani Lee, Sukjoon Yoon, Woo‐Young Kim · 2021 · Cells
- β-Catenin-CCL2 feedback loop mediates crosstalk between cancer cells and macrophages that regulates breast cancer stem cellsFan Zhang, Pan Li, Shuang Liu, Mingqiang Yang, Shanshan Zeng, Junjian Deng, Danyang Chen, Yanmei Yi, Hao Liu · 2021 · Oncogene
- WNT/β‐catenin pathway is a key regulator of cardiac function and energetic metabolismVolodymyr V. Balatskyi, Adrian Sówka, Paweł Dobrzyń, Oksana O. Piven · 2023 · Acta Physiologica
- YAP and β-catenin cooperate to drive H. pylori -induced gastric tumorigenesisNianshuang Li, Xinbo Xu, Yuan Zhan, Fei Xiao, Yaobin Ouyang, Pan Zheng, Yanan Zhou, Cong He, Chuan Xie, Yi Hu et al. · 2023 · Gut Microbes
- Genomic analysis and selective small molecule inhibition identifies BCL-XL as a critical survival factor in a subset of colorectal cancerHaichao Zhang, John Xue, Paul Hessler, Stephen K. Tahir, Jun Chen, Sha S Jin, Andrew James Souers, Joel D. Leverson, Lloyd T. Lam · 2015 · Molecular Cancer
- A TAZ-AXL-ABL2 Feed-Forward Signaling Axis Promotes Lung Adenocarcinoma Brain MetastasisJacob P. Hoj, Benjamin Mayro, Ann Marie Pendergast · 2019 · Cell Reports
- Functional Screening Identifies miRNAs Influencing Apoptosis and Proliferation in Colorectal CancerLise Lotte Christensen, Anja Holm, Juha Rantala, Olli Kallioniemi, Mads Heilskov Rasmussen, Marie S. Ostenfeld, Frederik Dagnæs‐Hansen, Bodil Øster, Troels Schepeler, Heidi Tobiasen et al. · 2014 · PLoS ONE
- Functional roles of SRC signaling in pancreatic cancer: Recent insights provide novel therapeutic opportunitiesAshleigh R. Poh, Matthias Ernst · 2023 · Oncogene
- Hippo-Independent Regulation of Yki/Yap/Taz: A Non-canonical ViewYong Suk Cho, Jin Jiang · 2021 · Frontiers in Cell and Developmental Biology
- CRB3 regulates contact inhibition by activating the Hippo pathway in mammary epithelial cellsXiaona Mao, Pingping Li, Yaochun Wang, Zheyong Liang, Jie Liu, Juan Li, Yina Jiang, Gang Bao, Lei Li, Bofeng Zhu et al. · 2017 · Cell Death and Disease
- Regulation of Tissue Growth by the Mammalian Hippo Signaling PathwayKevin I. Watt, Kieran F. Harvey, Paul Gregorevic · 2017 · Frontiers in Physiology
- A tightly controlled Src-YAP signaling axis determines therapeutic response to dasatinib in renal cell carcinomaJingya Sun, Xin Wang, Boyun Tang, Hong‐Chun Liu, Minmin Zhang, Yueqin Wang, Fangfang Ping, Jian Ding, Aijun Shen, Meiyu Geng · 2018 · Theranostics
- Functional and genomic analyses reveal therapeutic potential of targeting β-catenin/CBP activity in head and neck cancerVinay K. Kartha, Khalid A. Abalkhail, Khikmet Sadykov, Bach-Cuc Nguyen, Fabrice Laroche, Hui Feng, Jina Lee, Sara Isabel Pai, Xaralabos Varelas, Ann Marie Egloff et al. · 2018 · Genome Medicine
- Cadherins and catenins in cancer: connecting cancer pathways and tumor microenvironmentWan‐Hsin Lin, Lisa M. Cooper, Panos Z. Anastasiadis · 2023 · Frontiers in Cell and Developmental Biology
- The OncoPPi Portal: an integrative resource to explore and prioritize protein–protein interactions for cancer target discoveryAndrei A. Ivanov, Brian Revennaugh, Lauren E. Rusnak, Valentina González-Pecchi, Xiulei Mo, Margaret A. Johns, Yuhong Du, Lee Cooper, Carlos S. Moreno, Fadlo Raja Khuri et al. · 2017 · Bioinformatics
- Overview of Three Proliferation Pathways (Wnt, Notch, and Hippo) in Intestine and Immune System and Their Role in Inflammatory Bowel Diseases (IBDs)Seyed Mobin Khoramjoo, Nesa Kazemifard, Shaghayegh Baradaran Ghavami, Maryam Farmani, Shabnam Shahrokh, Hamid Asadzadeh Aghdaei, Ghazal Sherkat, Mohammad Reza Zali · 2022 · Frontiers in Medicine
- The YAP1/SIX2 axis is required for DDX3-mediated tumor aggressiveness and cetuximab resistance in KRAS-wild-type colorectal cancerDe‐Wei Wu, Po-Lin Lin, Lee Wang, Chi‐Chou Huang, Huei Lee · 2017 · Theranostics
- Emerging roles of YAP/TAZ in lung physiology and diseasesHaojun Xie, Li-Quan Wu, Zhenan Deng, Yating Huo, Yuanxiong Cheng · 2018 · Life Sciences
- Meta-Analysis and Systematic Review of the Genomics of Mucosal MelanomaNatasa Broit, Peter A. Johansson, Chloe B. Rodgers, Sebastian Walpole, Felicity Newell, Nicholas K. Hayward, Antonia L. Pritchard · 2021 · Molecular Cancer Research
- Targeting the Hippo pathway in heart repairFansen Meng, Bing Xie, James F. Martin · 2021 · Cardiovascular Research
- The Regulatory Machinery of Neurodegeneration in In Vitro Models of Amyotrophic Lateral SclerosisBurcin Ikiz, Mariano J. Alvarez, Diane Bérangère Ré, Virginia Le Verche, Kristin A. Politi, Francesco Lotti, Sudarshan Phani, Radhika Pradhan, Changhao Yu, Gist F. Croft et al. · 2015 · Cell Reports
- Capturing the mammalian Hippo: Elucidating its role in cancerMiki Nishio, Kohei Otsubo, Tomohiko Maehama, Koshi Mimori, Akira Suzuki · 2013 · Cancer Science
- Wnt activated β-catenin and YAP proteins enhance the expression of non-coding RNA component of RNase MRP in colon cancer cellsJinjoo Park, Sunjoo Jeong-Yu · 2015 · Oncotarget
- Probing the canonicity of the Wnt/Wingless signaling pathwayAlexandra Franz, Daria Shlyueva, Erich Brunner, Alexander Stark, Konrad Basler · 2017 · PLoS Genetics
- Yap1 safeguards mouse embryonic stem cells from excessive apoptosis during differentiationLucy LeBlanc, Bum‐Kyu Lee, Andy C Yu, Mijeong Kim, Aparna V Kambhampati, Shannon M. Dupont, Davide Seruggia, Byoung U Ryu, Stuart H. Orkin, Jonghwan Kim · 2018 · eLife
- Hippo‐Yap/Taz signaling: Complex network interactions and impact in epithelial cell behaviorBenjamin J. van Soldt, Wellington Veras Cardoso · 2019 · Wiley Interdisciplinary Reviews Developmental Biology
- Molecular Classification and Therapeutic Targets in EpendymomaThomas Larrew, Brian Fabian Saway, Stephen R. Lowe, Adriana Olar · 2021 · Cancers
- Prognostic Value of Yes-Associated Protein 1 (YAP1) in Various Cancers: A Meta-AnalysisZhenqiang Sun, Ruiwei Xu, Xiayu Li, Weiguo Ren, Chunlin Ou, Qisan Wang, Han Zhang, Xuemei Zhang, Jian Ma, Haijiang Wang et al. · 2015 · PLoS ONE
- Fat4 suppression induces Yap translocation accounting for the promoted proliferation and migration of gastric cancer cellsLiangang Ma, Jianxin Cui, Hongqing Xi, Shibo Bian, Bo Wei, Lin Chen · 2015 · Cancer Biology & Therapy
- Targeting loss of the Hippo signaling pathway in NF2-deficient papillary kidney cancersCarole Sourbier, Pei‐Jyun Liao, Christopher J. Ricketts, Darmood Wei, Youfeng Yang, Sarah M. Baranes, Benjamin K. Gibbs, Lernik Ohanjanian, Louis Spencer Krane, Bradley T. Scroggins et al. · 2018 · Oncotarget
- YAP-dependent ubiquitination and degradation of β-catenin mediates inhibition of Wnt signalling induced by Physalin F in colorectal cancerChen Chen, Dong‐Rong Zhu, Hao Zhang, Chao Han, Gui‐Min Xue, Tianyu Zhu, Jian‐Guang Luo, Lingyi Kong · 2018 · Cell Death and Disease
- YAP and the Hippo pathway in cholangiocarcinomaTakaaki Sugihara, Hajime Isomoto, Gregory James Gores, Rory L. Smoot · 2019 · Journal of Gastroenterology
- Integrating Genomics Into Clinical Pediatric Oncology Using the Molecular Tumor Board at the Memorial Sloan Kettering Cancer CenterMichael Vincent Ortiz, Rachel Kobos, Michael Francis Walsh, Emily Kanaya Slotkin, Stephen S. Roberts, Michael F. Berger, Meera Hameed, David B. Solit, Marc Ladanyi, Neerav Narendra Shukla et al. · 2016 · Pediatric Blood & Cancer
- The molecular rationale of Src inhibition in colorectal carcinomasGargalionis, Antonios N., Karamouzis, Michalis V., Papavassiliou, Athanasios G. · 2014 · International Journal of Cancer
- Hippo Signaling at the Hallmarks of Cancer and Drug ResistanceRamesh Kumar, Wanjin Hong · 2024 · Cells
- MiR-497 Suppresses YAP1 and Inhibits Tumor Growth in Non-Small Cell Lung CancerChongbiao Huang, Ruijue Ma, Jie Yue, Na Li, Zengxun Li, Daliang Qi · 2015 · Cellular Physiology and Biochemistry
- Targeting the Hippo signalling pathway for cancer treatmentKeisuke Nakatani, Tomohiko Maehama, Miki Nishio, Hiroki Goto, Wakako Kato, Hirofumi Omori, Yosuke Miyachi, Hideru Togashi, Yohei Shimono, Akira Suzuki · 2016 · The Journal of Biochemistry
- ZFP57 suppress proliferation of breast cancer cells through down-regulation of MEST-mediated Wnt/β-catenin signalling pathwayLie Chen, Xiaowei Wu, Hui Xie, Na Yao, Yiqin Xia, Ge Ma, Mengjia Qian, Han Ge, Yangyang Cui, Yue Huang et al. · 2019 · Cell Death and Disease
- Hippo Pathway and YAP Signaling Alterations in Squamous Cancer of the Head and NeckKarla Santos-de-Frutos, Carmen Segrelles, Corina Lorz · 2019 · Journal of Clinical Medicine
- YAP promotes sorafenib resistance in hepatocellular carcinoma by upregulating survivinTing Sun, Wenhao Mao, Hui Peng, Qi Wang, Lin Jiao · 2021 · Cellular Oncology
- Subversion of Niche-Signalling Pathways in Colorectal Cancer: What Makes and Breaks the Intestinal Stem CellNathalie Sphyris, Michael C. Hodder, Owen James Sansom · 2021 · Cancers
- The Hippo pathway: Organ size control and beyondPengfei Guo, Sicheng Wan, Kun‐Liang Guan · 2024 · Pharmacological Reviews
- Integration of mechanical and chemical signals by YAP and TAZ transcription coactivatorsXiaocan Guo, Bin Zhao · 2013 · Cell & Bioscience
- Targeting the Hippo pathway: Clinical implications and therapeuticsShuai Ye, T.S. Karin Eisinger‐Mathason · 2015 · Pharmacological Research
- Tissue inhibitor of metalloproteinase-1 promotes cell proliferation through YAP/TAZ activation in cancerToshinori Ando, Dyshafilia Charindra, Madhu Shrestha, Hanako Umehara, Ikuko Ogawa, Mutsumi Miyauchi, Takashi Takata · 2017 · Oncogene
- Repurposing of Drugs Targeting YAP-TEAD FunctionsGian Marco Elisi, Matteo Santucci, Domenico D’Arca, Angela Lauriola, Gaetano Marverti, Lorena Losi, Laura Scalvini, María Laura Bolognesi, Marco Mor, Maria Paola Costi · 2018 · Cancers